These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2263592)

  • 1. Nucleolar grading of renal cancer. Correlation of frequency and localization of nucleoli to histologic and cytologic grading and stage of renal cell carcinomas.
    Helpap B; Knüpffer J; Essmann S
    Mod Pathol; 1990 Nov; 3(6):671-8. PubMed ID: 2263592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histological and cytological (nucleolar) grading of renal cell carcinoma].
    Helpap B; Knüpffer J; Essmann S
    Verh Dtsch Ges Pathol; 1989; 73():400-4. PubMed ID: 2482626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR
    Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histological malignancy grade of renal cancer: karyo- and stereometric analysis].
    Iurin AG; Koval'skiĭ GB
    Arkh Patol; 2009; 71(2):13-8. PubMed ID: 19507571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
    Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.
    Sika-Paotonu D; Bethwaite PB; McCredie MR; William Jordan T; Delahunt B
    Am J Surg Pathol; 2006 Sep; 30(9):1091-6. PubMed ID: 16931953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.
    Hafez KS; Novick AC; Butler BP
    J Urol; 1998 Apr; 159(4):1156-60. PubMed ID: 9507821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of renal cancer and its metastases.
    Ulrich W; Buxbaum P; Holzner JH
    Semin Surg Oncol; 1988; 4(2):143-8. PubMed ID: 3393778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pax-2 expression in adult renal tumors.
    Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
    Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens.
    Ito K; Yoshii H; Asakuma J; Sato A; Horiguchi A; Sumitomo M; Hayakawa M; Asano T
    Jpn J Clin Oncol; 2009 Sep; 39(9):588-94. PubMed ID: 19556339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current state of renal cell carcinoma grading. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).
    Goldstein NS
    Cancer; 1997 Sep; 80(5):977-80. PubMed ID: 9307201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy index based on flow cytometry and histology for renal cell carcinomas and its correlation to prognosis.
    Baisch H; Otto U; Klöppel G
    Cytometry; 1986 Mar; 7(2):200-4. PubMed ID: 3948608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of volume weighted mean nuclear volume for predicting disease outcome in patients with renal cell carcinoma.
    Fujikawa K; Sasaki M; Aoyama T; Itoh T
    J Urol; 1997 Apr; 157(4):1237-41. PubMed ID: 9120910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
    Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine needle aspiration biopsy of renal cell carcinoma. Cytologic parameters and their concordance with histology and flow cytometric data.
    Cajulis RS; Katz RL; Dekmezian R; el-Naggar A; Ro JY
    Acta Cytol; 1993; 37(3):367-72. PubMed ID: 8498138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A partial nephrectomy in renal cell carcinoma].
    Masuda F; Suzuki H; Kurauchi H; Mitani H; Kawahara M; Nishida A
    Gan No Rinsho; 1989 Aug; 35(9):1025-9. PubMed ID: 2671430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
    Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
    Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar grading of breast cancer. Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry.
    Helpap B
    Virchows Arch A Pathol Anat Histopathol; 1989; 415(6):501-8. PubMed ID: 2552652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of tumor stage, size, grade, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma.
    Baltaci S; Orhan D; Soyupek S; Bedük Y; Tulunay O; Gögüs O
    J Urol; 2000 Jul; 164(1):36-9. PubMed ID: 10840419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.